Employer Approaches: Managing GLP-1s with Real-World Solutions As GLP-1 drugs become increasingly common in benefit discussions, companies are taking different approaches based on their size, budget, and plan structure
Additional considerations include: Hypoglycemia : Low risk as monotherapy but increased when combined with insulin or sulfonylureas
Laboratory monitoring should be done prior to beginning treatment and quarterly until maintenance dose is established
Concerns about ozempic and thyroid disorders stem from the interplay between metabolism, weight, and endocrine balance
Keywords: polycystic ovary syndrome, semaglutide, oxidative stress, autophagy Introduction Polycystic ovary syndrome (PCOS), a typical reproductive endocrine system disease with high incidence rate among childbearing age women, has developed into one of the important pathological factors leading to female infertility
Baseline laboratory testing typically includes HbA1c, fasting glucose, comprehensive metabolic panel to assess kidney function, and lipid profile